Companies begin to focus on insulin pens

06/5/2007 | Wall Street Journal, The

Insulin pens haven't been a huge success in the U.S., but manufacturers are hoping that more-attractive devices, better sales pitches and an offer of discounts will change that. Eli Lilly plans to launch three new pens this year, including a burgundy digital pen, and Sanofi-Aventis has created a disposable pen that it plans to market directly to consumers.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health